Cargando…

Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection

Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshaya, Omar A., Saleh, Rana A., Alshehri, Shaden D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366571/
https://www.ncbi.nlm.nih.gov/pubmed/34373441
http://dx.doi.org/10.12659/AJCR.932544
_version_ 1783738908066971648
author Alshaya, Omar A.
Saleh, Rana A.
Alshehri, Shaden D.
author_facet Alshaya, Omar A.
Saleh, Rana A.
Alshehri, Shaden D.
author_sort Alshaya, Omar A.
collection PubMed
description Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGROUND: Fusarium spp. is a rare cause of opportunistic life-threatening fungal infections. It has a remarkably high resistance profile with few effective antifungal agents, mostly limited to voriconazole and liposomal amphotericin B. Drug-induced liver injury (DILI) by 1 of these 2 antifungal agents further complicates the management of these infections. CASE REPORT: A 38-year-old woman with short bowel syndrome presented to the hospital with concerns of abdominal pain and loose stools. An abdominal CT was negative for inflammatory or ischemic bowel disease, and there was no evidence of liver disease. She tested positive for SARS-CoV-2 and required transfer to the ICU due to hypotension requiring fluid resuscitation and vasopressors. On day 43 of her admission, the patient developed a low-grade fever, for which she underwent central-line and peripheral-blood cultures that were positive for Fusarium dimerum. The central line was removed and i.v. voriconazole was started. After 3 days of treatment, the patient’s liver enzymes rose abruptly. Voriconazole was discontinued and replaced with liposomal amphotericin B, and the liver enzymes improved significantly. The patient completed 14 days of therapy and was discharged from the hospital. CONCLUSIONS: This is a case of F. dimerum infection followed by DILI from voriconazole treatment. Her infection was resolved after switching to liposomal amphotericin B, with improvement in liver enzymes on day 1 after discontinuing voriconazole. This observation demonstrates that altering antifungal classes may be an appropriate strategy when confronted with DILI.
format Online
Article
Text
id pubmed-8366571
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-83665712021-08-25 Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection Alshaya, Omar A. Saleh, Rana A. Alshehri, Shaden D. Am J Case Rep Articles Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGROUND: Fusarium spp. is a rare cause of opportunistic life-threatening fungal infections. It has a remarkably high resistance profile with few effective antifungal agents, mostly limited to voriconazole and liposomal amphotericin B. Drug-induced liver injury (DILI) by 1 of these 2 antifungal agents further complicates the management of these infections. CASE REPORT: A 38-year-old woman with short bowel syndrome presented to the hospital with concerns of abdominal pain and loose stools. An abdominal CT was negative for inflammatory or ischemic bowel disease, and there was no evidence of liver disease. She tested positive for SARS-CoV-2 and required transfer to the ICU due to hypotension requiring fluid resuscitation and vasopressors. On day 43 of her admission, the patient developed a low-grade fever, for which she underwent central-line and peripheral-blood cultures that were positive for Fusarium dimerum. The central line was removed and i.v. voriconazole was started. After 3 days of treatment, the patient’s liver enzymes rose abruptly. Voriconazole was discontinued and replaced with liposomal amphotericin B, and the liver enzymes improved significantly. The patient completed 14 days of therapy and was discharged from the hospital. CONCLUSIONS: This is a case of F. dimerum infection followed by DILI from voriconazole treatment. Her infection was resolved after switching to liposomal amphotericin B, with improvement in liver enzymes on day 1 after discontinuing voriconazole. This observation demonstrates that altering antifungal classes may be an appropriate strategy when confronted with DILI. International Scientific Literature, Inc. 2021-08-10 /pmc/articles/PMC8366571/ /pubmed/34373441 http://dx.doi.org/10.12659/AJCR.932544 Text en © Am J Case Rep, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Alshaya, Omar A.
Saleh, Rana A.
Alshehri, Shaden D.
Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
title Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
title_full Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
title_fullStr Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
title_full_unstemmed Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
title_short Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
title_sort voriconazole-induced hepatotoxicity resolved after switching to amphotericin b in fusarium dimerum central line-associated bloodstream infection
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366571/
https://www.ncbi.nlm.nih.gov/pubmed/34373441
http://dx.doi.org/10.12659/AJCR.932544
work_keys_str_mv AT alshayaomara voriconazoleinducedhepatotoxicityresolvedafterswitchingtoamphotericinbinfusariumdimerumcentrallineassociatedbloodstreaminfection
AT salehranaa voriconazoleinducedhepatotoxicityresolvedafterswitchingtoamphotericinbinfusariumdimerumcentrallineassociatedbloodstreaminfection
AT alshehrishadend voriconazoleinducedhepatotoxicityresolvedafterswitchingtoamphotericinbinfusariumdimerumcentrallineassociatedbloodstreaminfection